Related Experiment Video

Updated: Oct 9, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

A von Eckardstein1, J R Nofer, G Assmann

  • 1Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität Münster, Germany. vonecka@uni-muenster.de

Arteriosclerosis, Thrombosis, and Vascular Biology
|January 9, 2001
PubMed

Insights

High density lipoprotein (HDL) cholesterol is linked to heart disease. Its subclasses, not just levels, are key to cholesterol removal and reducing atherosclerosis risk.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism

Background:

  • High density lipoprotein (HDL) cholesterol is a significant risk factor for coronary heart disease.
  • HDL possesses antiatherogenic properties, notably mediating cholesterol efflux and reverse cholesterol transport (RCT) from arterial cells to the liver.
  • Enhancing cholesterol efflux and RCT is a primary therapeutic target for antiatherosclerotic drug development.

Purpose of the Study:

  • To investigate the determinants of reverse cholesterol transport (RCT) efficacy and its relationship with atherosclerosis risk.
  • To clarify the role of HDL subclasses and metabolism kinetics in RCT, beyond total HDL cholesterol levels.

Main Methods:

  • In vitro experiments
  • Genetic family and population studies
  • Investigation of transgenic animal models

Main Results:

  • HDL cholesterol plasma levels do not always correlate with RCT efficacy or antiatherogenicity.
  • Concentration of specific HDL subclasses is crucial for effective RCT.
  • Cellular lipid mobilization for efflux and HDL metabolism kinetics are critical factors in RCT.

Conclusions:

  • HDL subclasses, cellular lipid efflux, and HDL metabolism kinetics are more important determinants of RCT efficacy than total HDL cholesterol levels.
  • These factors significantly influence atherosclerosis risk.

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
Inflammation01:38

Inflammation

Overview